Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Tailored Patient Navigation to Boost Lung Cancer Screening in Tribal Communities

Official title: Strengthening Awareness and Community Resources for Early Detection of Lung Cancer Through Navigation Guided Screening Trial (SACRED LUNGS Aims 1.2-3)

Run by Fred Hutchinson Cancer Center · NCT07176000 · Data updated 2026-11-12

This trial tests whether customized patient navigation can help American Indian and Alaska Native people in western Washington start and complete lung cancer screening.

More Lung Carcinoma trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment237 (estimated)
SponsorFred Hutchinson Cancer Center
Academic / other
Locations2 sites (Auburn, Washington and 1 other locations)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedMarch 29, 2029
Study endsApril 30, 2029
Registry record updatedOctober 27, 2026
Trial IDNCT07176000 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 50–77 with a 20-pack-year smoking history and current tobacco use within the last 15 years who have been seen by a PCP at a participating clinic.

Probably not a fit

Individuals not interested in screening or not meeting the smoking history criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are randomized to receive either tailored patient navigation for 21 months plus an LCS educational handout, or enhanced usual care with a hand-off to discuss LCS followed by 15 months of navigation for those in the second arm. The study uses patient navigation, education, interviews, and surveys to support uptake and follow-up of low-dose CT screening for those aged 50–77 with a 20-pack-year smoking history and recent tobacco use. Settings are two tribal-affiliated clinics in Washington state, with activity spanning clinical staff and patient perspectives. The trial aims to understand how navigation strategies affect screening uptake among AI/AN communities and gather stakeholder insights.

Why it matters

Potential benefit: If successful, tailored navigation could increase lung cancer screening uptake and early detection in tribal communities.

How similar studies have gone: Previous work suggests navigation and targeted outreach can improve screening uptake in underserved populations, but results vary by community and setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Between ages 50-77
* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Self-reported 20-pack year smoking history
* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Ongoing commercial tobacco use within the past 15 years
* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Seen by a PCP at a participating clinic (South Puget Intertribal Planning Agency \[SPIPA\] or Muckleshoot) within the past three years

  * Potential participants who want to establish care at an eligible clinic will be connected to a PCP
* AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age
* AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member
* AIM 2 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1.2 trial
* AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age
* AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member
* AIM 3 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1.2 trial

Exclusion Criteria:

* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Has had a documented chest CT within the past one year
* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Personal history of lung cancer
* AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Personal history of any cancer within 5 years except for basal cell or squamous cell skin carcinoma

Where it's running

  • Muckleshoot Tribal Clinic
    Auburn, Washington, United States
    Recruiting
  • South Puget Intertribal Planning Agency (SPIPA)
    Shelton, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Matty Triplette, MD, MPH — Fred Hutch/University of Washington Cancer Consortium
  • Study coordinator: Matty Triplette, MD, MPH
  • Email: mtriplet@fredhutch.org
  • Phone: (206) 667-6335

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.